Pages with the fewest revisions
More actions
Showing below up to 50 results in range #501 to #550.
- Problem:Ehlers-Danlos Syndrome (1 revision)
- Effect:Pupil constriction (1 revision)
- Problem:Schizoaffective Disorder (1 revision)
- Effect:Compulsive redosing (1 revision)
- Problem:Generalized Anxiety Disorder (1 revision)
- Effect:Depression reduction (1 revision)
- Problem:Dry eye disease (1 revision)
- Effect:External hallucination (1 revision)
- Problem:Functional Neurological Disorder (1 revision)
- Effect:Olfactory hallucination (1 revision)
- Problem:Allergic rhinitis (1 revision)
- Alexander Shulgin (1 revision)
- Effect:Amnesia (1 revision)
- Problem:Avoidant/Restrictive Food Intake Disorder (1 revision)
- Levothyroxine (2 revisions)
- Anastrozole (2 revisions)
- Cetirizine (2 revisions)
- Phenotype:UGT1A1 normal metabolizer (2 revisions)
- Cefuroxime (2 revisions)
- Phenotype:CYP3A4 poor metabolizer (2 revisions)
- USLegal:Over-the-counter (2 revisions)
- Niacin (2 revisions)
- Fluconazole (2 revisions)
- Hydroxychloroquine (2 revisions)
- Tobramycin (2 revisions)
- Clindamycin (2 revisions)
- Epinephrine (2 revisions)
- Percodan (2 revisions)
- Dutasteride (2 revisions)
- Ceylon cinnamon (2 revisions)
- Fenofibrate (2 revisions)
- Ketotifen (2 revisions)
- Loperamide (2 revisions)
- Tamsulosin (2 revisions)
- Phenotype:CYP2C9 normal metabolizer (2 revisions)
- Nitrofurantoin (2 revisions)
- Phenotype:CYP2B6 poor metabolizer (2 revisions)
- Fluticasone (2 revisions)
- Empagliflozin (2 revisions)
- Polyethylene Glycol 3350 With Electrolytes (2 revisions)
- Spironolactone (2 revisions)
- Progesterone (2 revisions)
- Icosapent Ethyl (2 revisions)
- Nabumetone (2 revisions)
- Avanafil (2 revisions)
- Polyethylene Glycol 3350 (2 revisions)
- Ezetimibe (2 revisions)
- Phenotype:CYP2C19 normal metabolizer (2 revisions)
- Ofloxacin (2 revisions)
- Phenotype:TPMT poor metabolizer (2 revisions)